Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q29006536)
Watch
English
Tasigna
pharmaceutical product
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
pharmaceutical product
1 reference
European Medicines Agency product number
EMEA/H/C/000798
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000798/human_med_001079.jsp
retrieved
22 March 2017
mixture
1 reference
European Medicines Agency product number
EMEA/H/C/000798
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000798/human_med_001079.jsp
retrieved
22 March 2017
has active ingredient
nilotinib
1 reference
stated in
RxNorm
RxNorm ID
735866
retrieved
14 February 2018
therapeutic area
chronic myeloid leukemia
authority
European Medicines Agency
start time
19 November 2007
1 reference
European Medicines Agency product number
EMEA/H/C/000798
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000798/human_med_001079.jsp
retrieved
16 February 2017
stated in
European Medicines Agency
manufacturer
Novartis
1 reference
reference URL
https://www.novartis.com/about/products
Identifiers
European Medicines Agency product number
EMEA/H/C/000798
1 reference
European Medicines Agency product number
EMEA/H/C/000798
reference URL
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000798/human_med_001079.jsp
retrieved
22 March 2017
RxNorm ID
735866
0 references
PBS Drug Code
1309X
0 references
12868G
0 references
12858R
0 references
12885E
0 references
12887G
0 references
12867F
0 references
9171Q
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit